tolerability
Showing 1 - 25 of >10,000
Safety and Tolerability Trial in Neuss (ZP7570, Placebo)
Not yet recruiting
- Safety and Tolerability
- ZP7570
- Placebo
-
Neuss, North Rhine-Westphalia, GermanyProfil Institut für Stoffwechselforschung GmbH
Aug 18, 2023
Diabetic Foot Trial in London (Path Active)
Recruiting
- Diabetic Foot
- Path Active
-
London, United KingdomRoyal Free Hospital
Oct 11, 2023
Schizophrenia Trial (MDMA 40mg, MDMA 80mg, MDMA 120mg)
Not yet recruiting
- Schizophrenia
- MDMA 40mg
- +2 more
- (no location specified)
Mar 3, 2023
COVID-19 Trial in Melbourne (EG-COVII)
Recruiting
- COVID-19
- EG-COVII
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd- Melbourne
Oct 24, 2023
Healthy Volunteers Trial (ABBV-903, Placebo for ABBV-903)
Not yet recruiting
- Healthy Volunteers
- ABBV-903
- Placebo for ABBV-903
- (no location specified)
Aug 21, 2023
Tolerability in Pediatric Patients With Psoriasis
Not yet recruiting
- Moderate-to-severe Plaque Psoriasis
- Secukinumab
- (no location specified)
Nov 16, 2023
COVID-19 Trial (LMN-301)
Not yet recruiting
- COVID-19
- LMN-301
- (no location specified)
Sep 1, 2023
Primary Sclerosing Cholangitis Trial (Aramchol meglumine)
Not yet recruiting
- Primary Sclerosing Cholangitis
- Aramchol meglumine
- (no location specified)
Oct 17, 2023
Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)
Not yet recruiting
- Pulmonary Hypertension
- Interstitial Lung Disease
- LIQ861
- (no location specified)
Nov 10, 2023
Fabry's Disease Trial (AGALSIDASE BETA (GZ419828), Acetaminophen, Diphenhydramine)
Not yet recruiting
- Fabry's Disease
- AGALSIDASE BETA (GZ419828)
- +4 more
- (no location specified)
Aug 30, 2023
Transcranial Magnetic Stimulation Tolerability inFunctional
Recruiting
- Functional Neurological Disorder
-
Bobigny, FranceHUPSSD
Nov 20, 2023
Safety Issues, Healthy Volunteers Trial in Natal (N,N-Dimethyltryptamine, Placebo)
Recruiting
- Safety Issues
- Healthy Volunteers
- N,N-Dimethyltryptamine
- Placebo
-
Natal, RN, BrazilHospital Universitário Onofre Lopes
Jun 2, 2023
Healthy Trial in Turku (KAND567, Placebo)
Completed
- Healthy
- KAND567
- Placebo
-
Turku, FinlandClinical Research Services Turku (CRST)
Sep 1, 2023
Hypertension, Dyslipidemias Trial (CKD-348(6), CKD-828, D097, D337)
Not yet recruiting
- Hypertension
- Dyslipidemias
- CKD-348(6)
- CKD-828, D097, D337
- (no location specified)
Oct 29, 2023
Advanced Malignant Tumor Trial in Jinan (JS207)
Not yet recruiting
- Advanced Malignant Tumor
-
Jinan, Shandong, ChinaAffiliated Cancer Hospital of Shandong First Medical University
Aug 28, 2023
Intensive Cardiac Rehabilitation: Tolerability and Effectiveness
Enrolling by invitation
- Cardiac Disease
- (no location specified)
Jan 30, 2023
Aging Trial (Salvia haenkei 175mg, Salvia haenkei 350mg)
Not yet recruiting
- Aging
- Salvia haenkei 175mg
- Salvia haenkei 350mg
- (no location specified)
Jun 30, 2023